Eulerpool Terminal
The edge that pays for itself.
Current Regulus Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
8.67 USD
Median
8.16 USD
Max
11.55 USD
Min
7.07 USD
Buy
7
Hold
5
Sell
0
The average target price for Regulus Therapeutics is 8.67 USD.
The median price target of Regulus Therapeutics is 8.16 USD.
Stock analysts from many renowned investment banks are closely examining the Regulus Therapeutics stock. They conclude their professional Regulus Therapeutics stock analyses with a clear recommendation for the Regulus Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2025-07-01 | 6 | 6 | 0 | — |
| 2025-06-01 | 7 | 5 | 0 | 8.67 USD |
| 2025-05-01 | 7 | 5 | 0 | 8.98 USD |
| 2025-05-01 | 7 | 5 | 0 | 8.98 USD |
| 2025-04-01 | 11 | 1 | 0 | 12.04 USD |
| 2025-03-01 | 10 | 2 | 0 | 12.04 USD |
Regulus Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Regulus Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2027e | 88.00 M USD | -31.00 M USD | -0.47 USD |
| 2028e | 335.00 M USD | 97.00 M USD | 1.48 USD |
| 2029e | 686.00 M USD | 233.00 M USD | 3.56 USD |